I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Bevacizumab every 4 weeks is as effective as every 2 weeks ..:
Yildiz, Ramazan
;
Benekli, Mustafa
;
Ozkan, Metin
...
Journal of Cancer Research and Clinical Oncology. 138 (2012) 11 - p. 1845-1852 , 2012
Link:
https://doi.org/10.1007/s00432-012-1264-5
RT Journal T1 <Title>Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer</Title> UL https://suche.suub.uni-bremen.de/peid=cr-10.1007_s00432-012-1264-5&Exemplar=1&LAN=DE A1 Yildiz, Ramazan A1 Benekli, Mustafa A1 Ozkan, Metin A1 Alkis, Necati A1 Berk, Veli A1 Kaplan, Mehmet Ali A1 Ciltas, Aydin A1 Karaca, Halit A1 Durnali, Ayse Gok A1 Coskun, Ugur A1 Dikilitas, Mustafa A1 Sevinc, Alper A1 Dane, Faysal A1 Yetisyigit, Tarkan A1 Dogu, Gamze Gokoz A1 Buyukberber, Suleyman PB Springer Science and Business Media LLC YR 2012 SN 0171-5216 SN 1432-1335 JF Journal of Cancer Research and Clinical Oncology VO 138 IS 11 SP 1845 OP 1852 LK http://dx.doi.org/https://doi.org/10.1007/s00432-012-1264-5 DO https://doi.org/10.1007/s00432-012-1264-5 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
